These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1329679)

  • 1. Absence of a specific effect of free radicals on HLA-B27.
    MacLean IL; Lowdell MW; Blake DR; Lunec J; Archer JR
    Ann Rheum Dis; 1992 Aug; 51(8):963-4. PubMed ID: 1329679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulphydryl reactivity of the HLA-B27 epitope: accessibility of the free cysteine studied by flow cytometry.
    MacLean L; Macey M; Lowdell M; Badakere S; Whelan M; Perrett D; Archer J
    Ann Rheum Dis; 1992 Apr; 51(4):456-60. PubMed ID: 1375018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a free sulphydryl group on expression of HLA-B27 specificity.
    Archer JR; Whelan MA; Badakere SS; McLean IL; Archer IV; Winrow VR
    Scand J Rheumatol Suppl; 1990; 87():44-50. PubMed ID: 1701920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro mutagenesis of HLA-B27. Amino acid substitutions at position 67 disrupt anti-B27 monoclonal antibody binding in direct relation to the size of the substituted side chain.
    el-Zaatari FA; Sams KC; Taurog JD
    J Immunol; 1990 Feb; 144(4):1512-7. PubMed ID: 1689355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Status of an unpaired thiol group on the HLA-B27 epitope.
    McLean L; Perrett D; Winrow VR; Archer JR
    Clin Exp Immunol; 1989 Sep; 77(3):417-21. PubMed ID: 2478324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro mutagenesis of HLA-B27. Substitution of an unpaired cysteine residue in the alpha 1 domain causes loss of antibody-defined epitopes.
    Taurog JD; el-Zaatari FA
    J Clin Invest; 1988 Sep; 82(3):987-92. PubMed ID: 2458390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure.
    Allen RL; O'Callaghan CA; McMichael AJ; Bowness P
    J Immunol; 1999 May; 162(9):5045-8. PubMed ID: 10227970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A subset of HLA-B27 molecules contains peptides much longer than nonamers.
    Urban RG; Chicz RM; Lane WS; Strominger JL; Rehm A; Kenter MJ; UytdeHaag FG; Ploegh H; Uchanska-Ziegler B; Ziegler A
    Proc Natl Acad Sci U S A; 1994 Feb; 91(4):1534-8. PubMed ID: 8108441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of two human IgM monoclonal antibodies reactive with HLA-B27.
    Wölpl A; Toubert A; Siemoneit K; Eiermann TH; Neumayer H; Goldmann SF
    Tissue Antigens; 1995 Oct; 46(4):305-12. PubMed ID: 8560449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27 phenotyping with flow cytometry: further improvement by multiple monoclonal antibodies.
    Hoffmann JJ; Janssen WC
    Clin Chem; 1997 Oct; 43(10):1975-81. PubMed ID: 9342021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope mapping of human monoclonal antibodies to HLA-B27 by using natural and mutated antigenic variants.
    Weyl D; Hansen T; Deschamps Y; Hannestad K; Toubert A
    Hum Immunol; 1991 Aug; 31(4):271-6. PubMed ID: 1717416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monospecific HLA-B27 fluorescein isothiocyanate-conjugated monoclonal antibody for rapid, simple and accurate HLA-B27 typing.
    Pei R; Arjomand-Shamsai M; Deng CT; Cesbron A; Bignon JD; Lee JH
    Tissue Antigens; 1993 Apr; 41(4):200-3. PubMed ID: 8362412
    [No Abstract]   [Full Text] [Related]  

  • 13. Routine HLA-B27 typing by flow cytometry: differentiation of the products of HLA-B*2702, B*2705 and B*2708.
    Coates E; Darke C
    Eur J Immunogenet; 1998 Feb; 25(1):29-37. PubMed ID: 9587742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B27 and antigen presentation: at the crossroads between immune defense and autoimmunity.
    Sorrentino R; Böckmann RA; Fiorillo MT
    Mol Immunol; 2014 Jan; 57(1):22-7. PubMed ID: 23916069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testing the importance of each residue in a HLA-B27-binding peptide using monoclonal antibodies.
    Fukazawa T; Wang J; Huang F; Wen J; Tyan D; Williams KM; Raybourne RB; Yu DT
    J Immunol; 1994 Feb; 152(3):1190-6. PubMed ID: 8301123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric HLA-B27 screening: cross-reactivity patterns of commercially available anti-HLA-B27 monoclonal antibodies with other HLA-B antigens.
    Levering WH; Wind H; Sintnicolaas K; Hooijkaas H; Gratama JW
    Cytometry B Clin Cytom; 2003 Jul; 54(1):28-38. PubMed ID: 12827665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoplasmic reticulum aminopeptidase 1 (ERAP1) exhibits functionally significant interaction with HLA-B27 and relates to subtype specificity in ankylosing spondylitis.
    Haroon N; Tsui FW; Uchanska-Ziegler B; Ziegler A; Inman RD
    Ann Rheum Dis; 2012 Apr; 71(4):589-95. PubMed ID: 22355039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time.
    Cauli A; Dessole G; Vacca A; Porru G; Cappai L; Piga M; Bitti PP; Fiorillo MT; Sorrentino R; Carcassi C; Mathieu A
    Scand J Rheumatol; 2012 May; 41(3):214-8. PubMed ID: 22360441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of an HLA-B27 monoclonal antibody that also reacts with a 35-kD bacterial outer-membrane protein.
    Toubert A; Hamachi M; Raffoux C; Park MS; Yu DT
    Clin Exp Immunol; 1990 Oct; 82(1):16-20. PubMed ID: 1698580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-B27.
    Bowness P
    Annu Rev Immunol; 2015; 33():29-48. PubMed ID: 25861975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.